Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/26/2025

Administration of Silodosin via Percutaneous Endoscopic Gastrostomy (PEG) Tube

Preparation Requirements

  • Pharmacist consultation is recommended before delivering silodosin through a PEG tube to confirm route suitability and verify that no absorption‑site constraints exist. 1
  • Liquid formulations are preferred over solid dosage forms for PEG tube administration because they lower the risk of tube occlusion and improve dosing accuracy. 1
  • When only capsules are available, open the capsule and dissolve its contents in an appropriate volume of water (typically 15–30 mL) before administration. 1

Administration Technique

  • Flush the PEG tube with 30 mL of water before giving silodosin to ensure tube patency. 1
  • Administer silodosin separately from other medications, flushing with 30 mL of water between each drug to prevent drug‑drug interactions and precipitation. 1
  • Flush the PEG tube with 30 mL of water after silodosin delivery to guarantee complete administration and maintain tube patency. 1
  • Use ENFit‑standard syringes and connectors to avoid misconnections. 1

Critical Pitfalls to Avoid

  • Do not shake ENFit syringes to remove residue, as this can expose personnel to the medication and alter the delivered dose. 1
  • Do not mix silodosin with other medications or enteral formula before administration because of the risk of interactions and precipitation. 1
  • Ensure the PEG tube has an adequate lumen size (minimum 15 Charrière) to prevent clogging with medication preparations. 2

Tube Material Considerations

  • Polyurethane PEG tubes are preferred over silicone for medication administration due to better patency retention, although certain drugs may bind to polyurethane. 1

Clinical Context

  • Silodosin is an α1‑A adrenergic receptor blocker indicated for lower urinary tract symptoms associated with benign prostatic hyperplasia; patients with neurological disorders who require PEG tubes may also benefit from silodosin therapy. 3

REFERENCES

1

Medication Administration via PEG Tube [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Administration of Lactose through PEG Tubes [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026